Clinical Pharmacology & Biopharmaceutics
Open Access

Abstract

Globally, scientists work on finding new accurate modalities to set down, think and execute critical tasks within the living cells, then get out, as if being in a minute voyage to solve a threatening problem. In this voyage, either they could study an ancient uncovered disease or solve a previously unresolved problem. Human health seems to be a fascinating interest to make a great race and competition among scientists to introduce a gift to the humanity each single second. At the nano level, materials begin to demonstrate entirely new chemical and physical properties and can be stronger, lighter and highly soluble. The invention of nano and femto techniques and devices opened a new era in medical and pharmaceutical applications. Currently, cancer management in a very specific targeted manner could be achieved using nano gold and other metal particles, and nano-vehicles for boron delivery to tumor cells, with least side effects, although still in preclinical phases, but seems quite promising. Additionally, relevant applications were reported in surgery (femtolaser), cancer diagnosis, bio-detection of disease markers, molecular imaging, implant technology, tissue engineering, devices for drug, protein, gene and radionuclide delivery. Many medical nanotechnology applications are still in their infancy. One of the scientific achievements using femtosecond lasers was taking pictures of chemical reactions while they take place. Nanopharmacy: A few nano-devices were tested to deliver drugs into specific sites of human tissues to manage some diseases like cancer. In the future, drugs are planned to be packed into microscopic plastic spheres which can be inhaled, and new type of porous polymer particles for releasing drugs in an environment resembling lungs for respiratory diseases, also, robotics are planned for cell and tissue repair, no specific celling is known.

Biography

Nabil Mohie Abdel–Hamid is a Professor of Cancer Biology and Head of Department of Biochemistry, ex-Dean and Founder of Pharmacy College, Kafrelsheikh University, Egypt. He is the member of Higher Consulting Organization of Egyptian Scientists Council. He is the Deputy Director of Egyptian Association of Cancer Research. He is the Head of Drug Manufacturing Committee, Arab Union of Rights of Intellectual Property, and Arab League. He is a Member in The Arab Evaluators for Scientific Degree Promotions and Egyptian Evaluators for Scientific Degree Promotions. His research interest is Cancer Biology. He is a Principal Instructor of Hepatocellular Carcinoma Research Programs. His research goals are early detection and new trends in management of hepatocellular carcinoma, including chemo and radio sensitization to cancer therapy. He is the Editor in Chief for American Journal of Cancer Prevention, USA and Archives in Cancer Research, Spain. He is an Editorial Board Member for 20 International Journals. He published 46 international publications and 6 books (including 2 international, USA and UK).

Email: nabilmohie@yahoo.com